Cardiovascular Diseases

The Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E. is involved in cardiovascular research focused on major conditions such as acute coronary syndrome, atherosclerotic cardiovascular disease, and chronic heart failure. These studies are designed to test new treatments and prevention strategies that may reduce serious heart-related events and improve long-term outcomes.

  • Evaluating therapies aimed at lowering the risk of heart attack, stroke, and other major cardiovascular events
  • Studying treatment options for symptomatic heart failure and related complications
  • Exploring approaches for transthyretin amyloidosis with cardiac involvement

Overall, this research area combines prevention, symptom control, and outcome improvement across several important heart and vascular diseases.

Neoplasms

In medical oncology, the site is running trials across a broad range of cancers, including advanced breast cancer, gastric and gastroesophageal cancer, colorectal cancer, head and neck squamous cell carcinoma, and multiple myeloma. The main goal is to assess new cancer treatments and compare them with current standards of care.

  • Testing novel therapies for HER2-positive and HER2-low breast cancer
  • Evaluating treatment strategies for metastatic gastric and gastroesophageal junction cancer
  • Studying options for metastatic colorectal cancer and head and neck cancer

These studies reflect a strong focus on improving survival, disease control, and treatment selection for patients with difficult-to-treat solid tumors and blood cancers.

Digestive System Diseases

Research in digestive system diseases at this site centers on liver and biliary disorders, especially non-alcoholic steatohepatitis, primary biliary cholangitis, and locoregional hepatocellular carcinoma. The trials are aimed at improving disease control, slowing progression, and reducing the risk of serious liver-related complications.

  • Assessing treatments that may improve liver histology and reduce fibrosis
  • Studying therapies for primary biliary cholangitis and cirrhosis-related outcomes
  • Testing combined treatment approaches for hepatocellular carcinoma

This line of research supports better care for patients with chronic liver disease and cancer affecting the digestive system.

Nervous System Diseases

The site also contributes to neurology research, with studies in focal onset seizures and primary generalized tonic-clonic seizures. These trials are designed to assess whether new therapies can better reduce seizure frequency and support longer-term seizure management.

  • Evaluating medicines for better seizure control
  • Investigating longer-term treatment safety and tolerability in epilepsy
  • Improving quality of life for people living with recurring seizure disorders

This area reflects a practical focus on finding more effective and better-tolerated options for patients with chronic neurological conditions.

Nutritional and Metabolic Diseases

Within nutritional and metabolic diseases, the trials at this hospital address conditions such as non-alcoholic steatohepatitis and related metabolic liver problems. The research is centered on testing therapies that may improve disease activity and prevent progression to more advanced illness.

  • Studying treatments for metabolic liver disease and fibrosis
  • Assessing whether new therapies can reduce liver-related clinical events
  • Supporting better management of chronic conditions linked to metabolism and liver health

These studies aim to address both the underlying disease process and the long-term complications associated with metabolic dysfunction.

Other Research Areas

Some trials at Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E. span multiple therapeutic areas or do not fit neatly into a single category. These studies often focus on broader questions of treatment effectiveness, safety, and clinical benefit across complex diseases.

  • Comparing treatment strategies to identify the most effective care pathways
  • Evaluating supportive approaches that may help patients stay on planned cancer therapy
  • Assessing new options for diseases with overlapping cardiovascular, oncology, and metabolic features

This diverse portfolio shows a wide-ranging commitment to clinical research across several major medical specialties.